Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics

人类乳腺的分子谱分析表明,乳腺癌风险与具有祖细胞特征的p27(+)细胞群相关。

阅读:3
作者:Sibgat Choudhury ,Vanessa Almendro, Vanessa F Merino, Zhenhua Wu, Reo Maruyama, Ying Su, Filipe C Martins, Mary Jo Fackler, Marina Bessarabova, Adam Kowalczyk, Thomas Conway, Bryan Beresford-Smith, Geoff Macintyre, Yu-Kang Cheng, Zoila Lopez-Bujanda, Antony Kaspi, Rong Hu, Judith Robens, Tatiana Nikolskaya, Vilde D Haakensen, Stuart J Schnitt, Pedram Argani, Gabrielle Ethington, Laura Panos, Michael Grant, Jason Clark, William Herlihy, S Joyce Lin, Grace Chew, Erik W Thompson, April Greene-Colozzi, Andrea L Richardson, Gedge D Rosson, Malcolm Pike, Judy E Garber, Yuri Nikolsky, Joanne L Blum, Alfred Au, E Shelley Hwang, Rulla M Tamimi, Franziska Michor, Izhak Haviv, X Shirley Liu, Saraswati Sukumar, Kornelia Polyak

Abstract

Early full-term pregnancy is one of the most effective natural protections against breast cancer. To investigate this effect, we have characterized the global gene expression and epigenetic profiles of multiple cell types from normal breast tissue of nulliparous and parous women and carriers of BRCA1 or BRCA2 mutations. We found significant differences in CD44(+) progenitor cells, where the levels of many stem cell-related genes and pathways, including the cell-cycle regulator p27, are lower in parous women without BRCA1/BRCA2 mutations. We also noted a significant reduction in the frequency of CD44(+)p27(+) cells in parous women and showed, using explant cultures, that parity-related signaling pathways play a role in regulating the number of p27(+) cells and their proliferation. Our results suggest that pathways controlling p27(+) mammary epithelial cells and the numbers of these cells relate to breast cancer risk and can be explored for cancer risk assessment and prevention.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。